NCT07042685: An ongoing trial by The Methodist Hospital Research Institute
This trial is ongoing. It must report results 3 years, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07042685 |
|---|---|
| Title | Phase II Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib as First Line in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 27, 2026 |
| Completion date | Dec. 31, 2028 |
| Required reporting date | Dec. 31, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 22, 2026 |
| Days late | None |